These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 718023)

  • 1. [Resistance to plague of mice experimentally infected with "Yersinia enterocolitica" (author's transl)].
    Alonso JM; Joseph-François A; Mazigh D; Bercovier H; Mollaret HH
    Ann Microbiol (Paris); 1978; 129B(2):203-7. PubMed ID: 718023
    [No Abstract]   [Full Text] [Related]  

  • 2. Temperature-modulated immunogenicity to Yersinia pestis from Yersinia enterocolitica O3.
    Alonso JM; Hurtrel B; Mazigh D; Chalvignac MA; Mollaret HH
    Infect Immun; 1982 Apr; 36(1):423-5. PubMed ID: 7076305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against Yersinia infection induced by non-virulence-plasmid-encoded antigens.
    Simonet M; Berche P; Mazigh D; Veron M
    J Med Microbiol; 1985 Oct; 20(2):225-31. PubMed ID: 3900406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of monoclonal antibody to V antigen from Yersinia pestis.
    Sato K; Nakajima R; Hara F; Une T; Osada Y
    Contrib Microbiol Immunol; 1991; 12():225-9. PubMed ID: 1935094
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of the virulence-associated plasmids of Yersinia enterocolitica on its immunogenicity against Y. pestis.
    Mazigh D; Quilici ML; Mollaret HH
    Ann Microbiol (Paris); 1984; 135B(3):283-90. PubMed ID: 6532281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ecological interactions among Yersinia in their common reservoir, the rodent].
    Alonso JM
    Bull Soc Pathol Exot; 1999 Dec; 92(5 Pt 2):414-7. PubMed ID: 11000952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weak anamnestic responses of inbred mice to Yersinia F1 genetic vaccine are overcome by boosting with F1 polypeptide while outbred mice remain nonresponsive.
    Brandler P; Saikh KU; Heath D; Friedlander A; Ulrich RG
    J Immunol; 1998 Oct; 161(8):4195-200. PubMed ID: 9780193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague.
    Zauberman A; Cohen S; Levy Y; Halperin G; Lazar S; Velan B; Shafferman A; Flashner Y; Mamroud E
    Vaccine; 2008 Mar; 26(13):1616-25. PubMed ID: 18304706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity.
    Eyles JE; Butcher WA; Titball RW; Hill J
    Vaccine; 2007 Oct; 25(42):7301-6. PubMed ID: 17869388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross reactions in PHA test for plague antibodies.
    Sehgal S; Singh S; Srivastava L; Gupta HO
    J Commun Dis; 1984 Dec; 16(4):317-9. PubMed ID: 6535790
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunoglobulin isotypes produced by mice experimentally infected with Yersinia sp.
    de Medeiros BM; Giannini MJ; Falcão DP
    Contrib Microbiol Immunol; 1991; 12():117-22. PubMed ID: 1935077
    [No Abstract]   [Full Text] [Related]  

  • 12. [The dynamics of resistance to plague in white mice innoculated once with plague microbe fraction 1].
    Basova NN; Filimonova IuA
    Biull Eksp Biol Med; 1968 Feb; 65(2):83-6. PubMed ID: 5660908
    [No Abstract]   [Full Text] [Related]  

  • 13. [Some features of action of "murine" toxin and Yersinia pestis antigen fraction I in cells sensitive to animal plague].
    Aseeva LE; Mishan'kin MB; Goncharov EK; Shevchenko LA
    Biull Eksp Biol Med; 1995 Feb; 119(2):193-5. PubMed ID: 7670051
    [No Abstract]   [Full Text] [Related]  

  • 14. [The role of the Yersinia plasmid of calcium-dependency in the formation of the plague immunity].
    Byvalov AA; Darmov IV; Marakulin IV; Obrosova AG; Pogorel'skiĭ IP
    Mol Gen Mikrobiol Virusol; 2005; (4):25-9. PubMed ID: 16334222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of Yersiniae.
    Mazigh D; Quilici ML; Mollaret HH
    Contrib Microbiol Immunol; 1987; 9():304-11. PubMed ID: 3665511
    [No Abstract]   [Full Text] [Related]  

  • 16. Roles of V antigen in promoting virulence in Yersiniae.
    Une T; Nakajima R; Brubaker RR
    Contrib Microbiol Immunol; 1987; 9():179-85. PubMed ID: 3665496
    [No Abstract]   [Full Text] [Related]  

  • 17. Yersinia pestis Yop secretion protein F: purification, characterization, and protective efficacy against bubonic plague.
    Swietnicki W; Powell BS; Goodin J
    Protein Expr Purif; 2005 Jul; 42(1):166-72. PubMed ID: 15939303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plague and its agents (current state of our knowledge)].
    Knapp W
    Cah Med; 1970 Jul; 11(9):779-86. PubMed ID: 4989215
    [No Abstract]   [Full Text] [Related]  

  • 19. Transcriptional profiling of a mice plague model: insights into interaction between Yersinia pestis and its host.
    Liu H; Wang H; Qiu J; Wang X; Guo Z; Qiu Y; Zhou D; Han Y; Du Z; Li C; Song Y; Yang R
    J Basic Microbiol; 2009 Feb; 49(1):92-9. PubMed ID: 18759226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent survival of attenuated Yersinia pestis organisms with coexistence of chondroitin sulfate colloidal iron within guinea pig macrophages as an initial step of the induction of potent antiplague immunogenesis.
    Iiponen AL; Wake A; Fukaya F
    Contrib Microbiol Immunol; 1991; 12():230-4. PubMed ID: 1935095
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.